Medical Device Industry News

Study: DAPT duration after drug-eluting stent surgery unclear

May 26, 2015 by Fink Densford

A new study of patients treated with long-duration dual-antiplatelet therapies after the placement of drug-eluting stents shows a lower rate of heart attack but a higher risk for major bleeding events.

DAPT duration after drug-eluting stent surgery unclear

Patients treated with long-duration anti-platelet therapies after the placement of a drug-eluting stent showed lower rates of heart attack but higher rates of major bleeding events and a slight increase in mortality, according to a new study released today.

MassDevice.com +3 | The top 3 medtech stories for May 26, 2015

May 26, 2015 by MassDevice

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

 

Another halt for St. Jude Medical's European Nanostim trial

May 26, 2015 by Brad Perriello

St. Jude Medical calls another halt to its Nanostim clinical trial in Europe after serious adverse events surfaced in several patients.

Another halt for St. Jude Medical's Nanostim trial

Sorin shareholders OK Cyberonics Merger

May 26, 2015 by Fink Densford

Sorin's shareholders approve the Italian medical device firm's merger with U.S.-based Cyberonics.

Sorin shareholders OK Cyberonics Merger

Medtech trio sets $297m offering terms

May 26, 2015 by Brad Perriello

A trio of medical device companies - Evolent Health, EndoChoice and Corindus Vascular Robotics - sets terms for public offerings today that could bring in a collective $297 million.

IPO Tuesday: Medtech trio sets offering terms

A trio of medtech companies set terms for their upcoming public offerings today, announcing plans to raise a collective $297 million.

Medtech engineer starts high-tech wine company Coravin

May 26, 2015 by Fink Densford

Intrinsic Therapeutics' founder George Lambrecht starts Coravin, a high-tech wine device company that allows for untapped wine access.

Medtech engineer starts high-tech wine company Coravin

Medtech engineer and founder of Intrinsic Therapeutics George Lambrecht has formed Coravin, a high-tech wine company that produces a device for tapping wine bottles without removing the cork.